全文获取类型
收费全文 | 111281篇 |
免费 | 8656篇 |
国内免费 | 9019篇 |
专业分类
128956篇 |
出版年
2024年 | 243篇 |
2023年 | 1434篇 |
2022年 | 3310篇 |
2021年 | 5582篇 |
2020年 | 3863篇 |
2019年 | 4773篇 |
2018年 | 4545篇 |
2017年 | 3312篇 |
2016年 | 4738篇 |
2015年 | 6884篇 |
2014年 | 8064篇 |
2013年 | 8544篇 |
2012年 | 10294篇 |
2011年 | 9258篇 |
2010年 | 5728篇 |
2009年 | 5135篇 |
2008年 | 5929篇 |
2007年 | 5312篇 |
2006年 | 4624篇 |
2005年 | 3620篇 |
2004年 | 3094篇 |
2003年 | 2804篇 |
2002年 | 2339篇 |
2001年 | 1894篇 |
2000年 | 1724篇 |
1999年 | 1695篇 |
1998年 | 1044篇 |
1997年 | 1016篇 |
1996年 | 954篇 |
1995年 | 833篇 |
1994年 | 800篇 |
1993年 | 626篇 |
1992年 | 829篇 |
1991年 | 630篇 |
1990年 | 474篇 |
1989年 | 456篇 |
1988年 | 362篇 |
1987年 | 351篇 |
1986年 | 269篇 |
1985年 | 289篇 |
1984年 | 162篇 |
1983年 | 164篇 |
1982年 | 102篇 |
1981年 | 86篇 |
1980年 | 64篇 |
1979年 | 77篇 |
1977年 | 59篇 |
1975年 | 60篇 |
1974年 | 54篇 |
1973年 | 60篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
961.
北京地区热力景观格局及典型城市景观的热环境效应 总被引:10,自引:1,他引:9
城市热环境是城市生态环境中的一个重要指标,将景观生态学理论融入到热环境研究中,尝试探讨北京地区热力景观格局及城市公园、道路景观的热环境效应。地表温度反演是分析热力景观格局及典型城市景观热环境效应的前提,论文以北京地区为例,首先利用两景ASTER影像数据采用TES算法定量反演地表温度。通过半变异函数分析地表温度空间异质性,确定最大采样尺度,然后在景观统计软件Fragstats中,计算不同粒度下的景观格局指数,分析热力景观格局及其尺度效应。通过景观斑块特征分析和缓冲区分析,探讨公园景观斑块、道路景观廊道特征的热环境效应。总体上公园景观对应的平均温度随着公园面积、边界长度的增加而减小,随着公园周长面积比增大而增大;随着距离公园渐远,地表温度升高,且升温趋势变缓。随着道路密度增加,道路平均温度显著升高,标准差显著降低,道路密度等级与道路平均温度的相关系数达到0.8021;随着距离道路中心线距离增加,缓冲区内的平均温度略有下降,但变化微弱。因此,应充分重视公园景观在缓解城市热环境方面的作用,合理布局城市道路。 相似文献
962.
蓝藻伪空胞的特性及浮力调节机制 总被引:5,自引:0,他引:5
伪空胞为蓝藻在水体中提供浮力,使其获得适宜的生长条件,最终导致蓝藻水华暴发,了解伪空胞的特征对控制蓝藻水华暴发有重要意义。文章简要回顾了蓝藻伪空胞自1865年被Klebahn发现到1965年被正式命名的研究历程,目前已发现150多种原核生物中含有伪空胞;伪空胞是两末端呈圆锥状的中空圆柱体,伪空胞半径与临界压强遵循方程:Pc=275(r/nm)-1.67MPa;伪空胞气体含量可根据不同原理,利用Walsby伪空胞测定装置、压力浊度计和细胞流式仪测得。总结了伪空胞组成的化学特性,评述了伪空胞gvp基因丛结构功能和GvpA、GvpC的蛋白空间结构。GvpA是伪空胞合成的主要成分,gvpA在伪空胞内存在多个拷贝,其功能仍不清楚;GvpC由33个氨基酸重复单位组成,重复单位越多,伪空胞越不易破裂;概述了伪空胞3种浮力调节机制:镇重物的改变、伪空胞的合成、伪空胞的破裂;归纳了环境因子(光照、温度、氮、磷、钾)参与伪空胞浮力网络调控的途径。提出了目前伪空胞研究面临的困难和问题,对伪空胞的未来研究方向提出探索性的建议。 相似文献
963.
964.
Toll样受体4与肝损伤的研究进展 总被引:1,自引:0,他引:1
Toll样受体4((toll like receptor4,TLR4)是内毒素(LPS)的关键受体,为Toll蛋白家族中的一个成员,是联系固有免疫和适应性免疫的纽带。TLR4主要表达于髓源性细胞,其启动的胞内信号转导在肝损伤的发生和发展过程中发挥重要作用。这一信号转导途径主要通过NF-κB、p38、JNK等的激活,使细胞产生炎症转录因子,介导肝脏炎症。TLR4与氧化应激的相互作用,使得肝脏对TLR4的配体及细胞因子的敏感性增加,从而加重肝脏损伤。随着TLR4在肝损伤中的作用进一步阐明,其在肝脏疾病中的治疗作用将会产生广阔的应用前景。 相似文献
965.
966.
Fei Huang Puiian Wong Jinglan Li Zheng Lv Liangliang Xu Genfu Zhu Mincong He Yiwen Luo 《Journal of cellular and molecular medicine》2022,26(13):3591
Osteoporosis is a bone disease that is caused by disorder of the skeletal microenvironment, and it characterized by a high disability rate and the occurrence of low energy fractures. Studies on osteoporosis and related treatment options have always been hot spots in the field of bone biology. In the past, the understanding of osteoporosis has been rather limited; research has only shown that osteoporosis involves the imbalance of bone resorption and bone formation, and recent studies have not provided cutting‐edge theories of the basic understanding of osteoporosis. Recent studies have shown crosstalk between bone and immune responses. RANKL, an essential factor for osteoclasts (OCs), is associated with the immune system. T helper (Th17)/regulatory T (Treg) cells are two different kinds of T cells that can self‐interact and regulate the differentiation and formation of OCs. Therefore, understanding the correlation between the skeletal and immune systems and further revealing the roles and the cooperation between RANKL and the Th17/Treg balance will help to provide new insights for the treatment of osteoporosis. 相似文献
967.
Yiwen Liu Jianfang Gao Min Xu Qianqian Zhou Zhongxiao Zhang Jiaxin Ye Rui Li 《Journal of cellular and molecular medicine》2022,26(13):3616
Congenital heart disease (CHD) is the most common birth defect, affecting approximately 1% of live births. Genetic and environmental factors are leading factors to CHD, but the mechanism of CHD pathogenesis remains unclear. Circular RNAs (circRNAs) are kinds of endogenous non‐coding RNAs (ncRNAs) involved in a variety of physiological and pathological processes, especially in heart diseases. In this study, three significant differently expressed circRNA between maternal embryonic day (E) E13 and E17 was found by microarray assay. Among them, the content of circ‐RCCD increases with the development of heart and was enriched in primary cardiomyocytes of different species, which arouses our attention. Functional experiments revealed that inhibition of circ‐RCCD dramatically suppressed the formation of beating cell clusters, the fluorescence intensity of cardiac differentiation marker MF20, and the expression of the myocardial‐specific markers CTnT, Mef2c, and GATA4. Next, we found that circ‐RCCD was involved in cardiomyocyte differentiation through negative regulation of MyD88 expression. Further experiments proved that circ‐RCCD inhibited MyD88 levels by recruiting YY1 to the promoter of MyD88; circ‐RCCD inhibited nuclear translocation of YY1. These results reported that circ‐RCCD promoted cardiomyocyte differentiation by recruiting YY1 to the promoter of MyD88. And, this study provided a potential role and molecular mechanism of circ‐RCCD as a target for the treatment of CHD. 相似文献
968.
969.
970.
Yueshui Zhao Sipeng Guo Jian Deng Jing Shen Fukuan Du Xu Wu Yu Chen Mingxing Li Meijuan Chen Xiaobing Li Wanping Li Li Gu Yuhong Sun Qinglian Wen Jing Li Zhangang Xiao 《International journal of biological sciences》2022,18(9):3845
Non-small cell lung cancer (NSCLC) is the leading cause of death by cancer worldwide. Despite developments in therapeutic approaches for the past few decades, the 5-year survival rate of patients with NSCLC remains low. NSCLC tumor is a complex, heterogeneous microenvironment, comprising blood vessels, cancer cells, immune cells, and stroma cells. Vascular endothelial growth factors (VEGFs) are a major mediator to induce tumor microvasculature and are associated with the progression, recurrence, and metastasis of NSCLC. Current treatment medicines targeting VEGF/VEGF receptor (VEGFR) pathway, including neutralizing antibodies to VEGF or VEGFR and receptor tyrosine kinase inhibitors, have shown good treatment efficacy in patients with NSCLC. VEGF is not only an important angiogenic factor but also an immunomodulator of tumor microenvironment (TME). VEGFs can suppress antigen presentation, stimulate activity of regulatory T (Treg) cells, and tumor-associated macrophages, which in turn promote an immune suppressive microenvironment in NSCLC. The present review focuses on the angiogenic and non-angiogenic functions of VEGF in NSCLC, especially the interaction between VEGF and the cellular components of the TME. Additionally, we discuss recent preclinical and clinical studies to explore VEGF/VEGFR-targeted compounds and immunotherapy as novel approaches targeting the TME for the treatment of NSCLC. 相似文献